Roche Gets FDA Approval for Malaria Screen Test
By Pierre Bertrand
Roche Holding said it received regulatory approval in the U.S. for its molecular test that screens for the presence of malaria in donated blood.
The U.S. Food and Drug Administration approved the company's Cobas Malaria test, Roche said in a statement Tuesday, adding that it was the first such approved test to screen U.S. blood donors for malaria by the federal body.
The tests will be available in the U.S. at the end of the second quarter this year. Approval in European Union countries is anticipated later this year, Roche said.
Write to Pierre Bertrand at pierre.bertrand@wsj.com
(END) Dow Jones Newswires
March 26, 2024 13:19 ET (17:19 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What Does Nvidia’s Stock Split Mean for Investors?
-
5 Undervalued Stocks to Buy as Their Stories Play Out
-
Markets Brief: Return of the Meme Stocks
-
What’s Happening In the Markets This Week
-
It’s Been a Terrible Time for Bonds. Here’s Why You Should Own Them
-
Which AI Stocks Are Turning Hype Into Revenue?
-
Best- and Worst-Performing Stocks of May 2024
-
3 Stocks to Buy and 3 Stocks to Sell in June
-
After Earnings, Is Nio Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Lululemon Stock a Buy, a Sell, or Fairly Valued?
-
The 10 Best Dividend Stocks
-
The Most Attractive Investment Opportunities in Oil & Gas
-
Apple: Generative AI Strategy Should Drive Sales and Upgrades
-
2 Undervalued Stocks That Just Raised Dividends
-
2 Popular Stocks That Top Managers Are Selling
-
The Best REITs to Buy